Index RUT
P/E -
EPS (ttm) -0.63
Insider Own 32.07%
Shs Outstand 121.83M
Perf Week 8.70%
Market Cap 142.36M
Forward P/E -
EPS next Y -0.79
Insider Trans 0.66%
Shs Float 96.71M
Perf Month 0.07%
Income -89.35M
PEG -
EPS next Q -0.20
Inst Own 31.45%
Short Float 6.20%
Perf Quarter -23.66%
Sales 1.70M
P/S 83.74
EPS this Y 1.47%
Inst Trans -1.76%
Short Ratio 7.46
Perf Half Y -47.09%
Book/sh 1.64
P/B 0.61
EPS next Y -17.91%
ROA -29.89%
Short Interest 5.99M
Perf Year -52.15%
Cash/sh 1.53
P/C 0.65
EPS next 5Y -
ROE -32.58%
52W Range 0.73 - 2.43
Perf YTD -50.25%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -38.30%
52W High -58.85%
Beta 2.89
Dividend TTM -
Quick Ratio 20.13
Sales past 5Y 0.00%
Gross Margin -223.38%
52W Low 36.61%
ATR (14) 0.08
Dividend Ex-Date -
Current Ratio 20.57
EPS Y/Y TTM 22.49%
Oper. Margin -5999.65%
RSI (14) 55.07
Volatility 9.53% 8.00%
Employees 165
Debt/Eq 0.01
Sales Y/Y TTM 270.81%
Profit Margin -5249.65%
Recom 2.00
Target Price 2.75
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 9.96%
Payout -
Rel Volume 0.90
Prev Close 0.98
Sales Surprise -11.65%
EPS Surprise 13.51%
Sales Q/Q 203.41%
Earnings Aug 07 AMC
Avg Volume 803.46K
Price 1.00
SMA20 5.88%
SMA50 2.20%
SMA200 -32.93%
Trades
Volume 725,249
Change 2.03%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-08-23 Initiated
H.C. Wainwright
Buy
$3
Sep-25-23 Downgrade
Canaccord Genuity
Buy → Hold
$3.50 → $2
Oct-20-21 Initiated
Canaccord Genuity
Buy
$13
Sep-04-24 06:00AM
Aug-27-24 06:01PM
04:30PM
Aug-26-24 06:00AM
Aug-07-24 04:02PM
04:05PM
Loading…
Jul-30-24 04:05PM
Jul-17-24 04:05PM
Jul-09-24 03:56PM
Jun-10-24 09:00AM
May-31-24 08:00AM
May-30-24 04:05PM
May-09-24 04:01PM
Apr-30-24 08:30AM
Apr-18-24 04:05PM
Mar-21-24 04:05PM
12:01PM
Loading…
Mar-07-24 12:01PM
Feb-29-24 04:05PM
Feb-27-24 08:30AM
Feb-09-24 08:00AM
Feb-05-24 08:00AM
Jan-18-24 08:30AM
Dec-12-23 08:30AM
Nov-15-23 08:30AM
Nov-11-23 09:18AM
Nov-09-23 04:05PM
(Business Wire) +7.26%
+6.77%
Nov-08-23 08:15AM
Nov-01-23 08:30AM
Oct-31-23 08:00AM
Oct-17-23 08:30AM
Oct-05-23 06:36PM
08:00AM
Loading…
08:00AM
Oct-03-23 08:00AM
Sep-21-23 08:00AM
Aug-22-23 07:05AM
Aug-16-23 04:00PM
Aug-14-23 06:02PM
Aug-07-23 08:00AM
Jul-26-23 08:00AM
Jul-18-23 04:00PM
Jun-21-23 08:00AM
Jun-07-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-11-23 04:00PM
(Business Wire) -5.52%
-8.44%
May-02-23 08:00AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-14-23 08:00AM
Mar-24-23 08:00AM
Mar-06-23 08:00AM
Feb-17-23 08:00AM
Feb-13-23 04:00PM
Jan-09-23 08:00AM
08:00AM
08:00AM
Dec-22-22 04:05PM
Dec-20-22 08:00AM
Dec-08-22 08:00AM
Nov-07-22 04:05PM
Nov-03-22 04:00PM
Oct-17-22 04:05PM
Oct-13-22 02:00PM
Oct-04-22 08:00AM
Aug-26-22 08:00AM
Aug-08-22 04:02PM
Jul-29-22 08:30AM
Jul-18-22 04:42PM
Jun-22-22 08:45AM
Jun-16-22 04:30PM
Jun-01-22 08:45AM
May-25-22 08:00AM
May-17-22 11:00AM
May-10-22 08:00AM
May-09-22 04:05PM
04:01PM
Apr-18-22 04:13PM
Mar-28-22 04:05PM
Mar-14-22 12:39PM
Feb-28-22 04:05PM
(Business Wire) -5.88%
+13.46%
Feb-18-22 09:21AM
Feb-14-22 04:05PM
Feb-07-22 04:05PM
Jan-10-22 04:10PM
(Business Wire) -9.15%
+7.51%
Jan-04-22 08:00AM
Dec-21-21 08:00AM
Dec-14-21 09:25AM
Dec-02-21 10:15AM
Nov-10-21 04:05PM
Nov-09-21 08:00AM
Nov-04-21 04:05PM
Oct-19-21 04:15PM
Sep-21-21 04:15PM
Sep-13-21 11:26AM
Aug-16-21 04:05PM
Aug-11-21 07:00AM
Jul-27-21 08:30AM
Jun-24-21 04:05PM
Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hawkins Jeffrey Alan President & CEO Aug 09 '24 Buy 0.85 25,000 21,272 1,003,757 Aug 13 06:01 AM LaPointe Christian General Counsel & Corp. Secr. Aug 09 '24 Buy 0.86 25,000 21,610 571,710 Aug 13 06:01 AM Keyes Jeffry R. Chief Financial Officer Aug 09 '24 Buy 0.87 50,000 43,465 446,820 Aug 13 06:01 AM Kummeth Charles R. Director Aug 09 '24 Buy 0.87 138,900 120,926 323,900 Aug 13 06:01 AM Kummeth Charles R. Director Aug 12 '24 Buy 0.89 31,100 27,533 355,000 Aug 13 06:01 AM Johnston Grace Chief Commercial Officer Jun 21 '24 Sale 1.21 4,359 5,262 299,109 Jun 25 07:18 PM Johnston Grace Chief Commercial Officer Jun 24 '24 Sale 1.20 3,169 3,790 295,940 Jun 25 07:18 PM Hawkins Jeffrey Alan President & CEO Mar 14 '24 Buy 1.76 25,000 44,000 25,000 Mar 18 08:21 AM LaPointe Christian General Counsel & Corp. Secr. Mar 15 '24 Buy 1.74 10,000 17,400 257,693 Mar 18 08:07 AM Keyes Jeffry R. Chief Financial Officer Mar 05 '24 Buy 1.61 50,000 80,500 50,000 Mar 06 05:09 PM
Index S&P 500
P/E 73.24
EPS (ttm) 1.04
Insider Own 1.06%
Shs Outstand 158.22M
Perf Week 4.11%
Market Cap 12.14B
Forward P/E 35.27
EPS next Y 2.17
Insider Trans -1.18%
Shs Float 156.97M
Perf Month 2.03%
Income 168.08M
PEG 6.51
EPS next Q 0.38
Inst Own 99.39%
Short Float 2.08%
Perf Quarter 2.64%
Sales 1.16B
P/S 10.47
EPS this Y 4.54%
Inst Trans 1.96%
Short Ratio 3.33
Perf Half Y 8.13%
Book/sh 13.08
P/B 5.85
EPS next Y 17.25%
ROA 6.06%
Short Interest 3.27M
Perf Year 7.50%
Cash/sh 0.96
P/C 79.41
EPS next 5Y 11.25%
ROE 8.33%
52W Range 51.79 - 85.57
Perf YTD -0.84%
Dividend Est. 0.25 (0.33%)
P/FCF 51.41
EPS past 5Y 11.13%
ROI 6.79%
52W High -10.59%
Beta 1.27
Dividend TTM 0.32 (0.42%)
Quick Ratio 2.75
Sales past 5Y 10.61%
Gross Margin 66.70%
52W Low 47.73%
ATR (14) 2.26
Dividend Ex-Date Aug 19, 2024
Current Ratio 3.87
EPS Y/Y TTM -41.27%
Oper. Margin 21.42%
RSI (14) 59.56
Volatility 2.94% 2.94%
Employees 3100
Debt/Eq 0.20
Sales Y/Y TTM 1.97%
Profit Margin 14.50%
Recom 1.62
Target Price 83.17
Option/Short Yes / Yes
LT Debt/Eq 0.20
EPS Q/Q -45.81%
Payout 30.61%
Rel Volume 0.85
Prev Close 75.28
Sales Surprise -0.13%
EPS Surprise -0.99%
Sales Q/Q 1.59%
Earnings Aug 07 BMO
Avg Volume 981.80K
Price 76.51
SMA20 5.16%
SMA50 2.00%
SMA200 4.61%
Trades
Volume 834,047
Change 1.63%
Date
Action
Analyst
Rating Change
Price Target Change
May-22-24 Downgrade
Citigroup
Buy → Neutral
$85
Feb-08-24 Initiated
Scotiabank
Sector Outperform
$80
Feb-02-24 Downgrade
Stifel
Buy → Hold
$65
Dec-07-23 Initiated
UBS
Buy
$80
Aug-28-23 Initiated
William Blair
Outperform
Jan-10-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$90
Dec-14-22 Initiated
Deutsche Bank
Buy
$100
Dec-12-22 Upgrade
Citigroup
Neutral → Buy
$81.25 → $100
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$89
Aug-25-22 Initiated
Credit Suisse
Outperform
$465
Apr-25-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$370
Sep-15-21 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$600
Mar-08-21 Upgrade
Stephens
Equal-Weight → Overweight
$380 → $425
Feb-23-21 Upgrade
Stifel
Hold → Buy
$435
Jan-25-21 Reiterated
The Benchmark Company
Buy
$320 → $410
Nov-10-20 Initiated
KeyBanc Capital Markets
Sector Weight
$340
Sep-30-20 Initiated
Atlantic Equities
Overweight
$365
Jul-15-20 Downgrade
Stephens
Overweight → Equal-Weight
May-27-20 Downgrade
Stifel
Buy → Hold
$245 → $260
May-14-20 Initiated
The Benchmark Company
Buy
$290
Show Previous Ratings
Today 07:00AM
07:00AM
Sep-17-24 07:00AM
07:00AM
Sep-16-24 07:00AM
05:11AM
Loading…
Sep-09-24 05:11AM
Aug-27-24 07:00AM
Aug-26-24 07:00AM
Aug-23-24 01:04AM
Aug-08-24 02:28PM
Aug-07-24 07:20PM
(Morningstar Research) -9.51%
06:30AM
06:30AM
Jul-31-24 07:00AM
Jul-29-24 07:00AM
07:00AM
Loading…
Jul-15-24 07:00AM
Jul-12-24 06:58PM
Jul-09-24 06:00AM
Jul-02-24 07:06PM
May-31-24 07:00AM
May-30-24 07:00AM
May-29-24 07:00AM
May-23-24 10:26AM
07:00AM
May-22-24 07:00AM
May-20-24 01:34PM
May-14-24 04:49AM
May-08-24 07:00AM
May-07-24 07:00AM
May-06-24 05:57AM
11:40AM
Loading…
May-02-24 11:40AM
11:31AM
10:49AM
10:34AM
08:17AM
08:00AM
03:11AM
May-01-24 04:54PM
02:05PM
01:52PM
12:08PM
11:10AM
09:30AM
08:36AM
07:51AM
07:40AM
07:29AM
06:30AM
06:30AM
Apr-30-24 07:00AM
Apr-29-24 10:38AM
09:39AM
07:00AM
Apr-26-24 07:00AM
Apr-24-24 10:01AM
Apr-23-24 07:00AM
Apr-10-24 07:00AM
Apr-08-24 07:00AM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
Mar-28-24 09:00AM
08:39AM
Mar-22-24 07:00AM
Mar-18-24 08:01PM
Mar-17-24 08:50AM
Mar-12-24 07:00AM
Mar-11-24 07:00PM
Mar-06-24 07:00AM
Feb-23-24 06:15AM
Feb-13-24 08:00AM
Feb-02-24 10:47AM
04:45AM
(Thomson Reuters StreetEvents)
Feb-01-24 12:57PM
07:51AM
07:07AM
06:30AM
06:30AM
Jan-29-24 07:00AM
Jan-25-24 07:00AM
Jan-24-24 07:00AM
Jan-21-24 01:16PM
Jan-16-24 07:00AM
Jan-05-24 07:00AM
Jan-04-24 07:00AM
Dec-21-23 07:00AM
Dec-20-23 07:00AM
Dec-14-23 07:00AM
Dec-01-23 01:32AM
Nov-27-23 07:00AM
Nov-13-23 07:00AM
Nov-02-23 07:00AM
Nov-01-23 10:44AM
Oct-31-23 07:53AM
07:27AM
06:30AM
06:30AM
Oct-25-23 03:42PM
09:00AM
Oct-22-23 10:30AM
Oct-20-23 05:01AM
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HIGGINS JOHN L Director Sep 12 '24 Option Exercise 22.95 6,000 137,700 48,608 Sep 16 04:18 PM Kelderman Kim Chief Executive Officer Aug 29 '24 Option Exercise 66.97 1,492 99,919 41,434 Sep 03 04:05 PM Bohnen Shane SVP - General Counsel Aug 15 '24 Option Exercise 0.00 49 0 1,696 Aug 19 05:28 PM BAUMGARTNER ROBERT V Director Aug 08 '24 Option Exercise 22.95 16,000 367,200 59,401 Aug 12 04:08 PM BAUMGARTNER ROBERT V Director Aug 08 '24 Sale 72.10 16,000 1,153,664 43,401 Aug 12 04:08 PM ROBERT V. BAUMGARTNER Director Aug 08 '24 Proposed Sale 72.10 16,000 1,153,664 Aug 08 04:13 PM Hippel James CFO Aug 02 '24 Option Exercise 31.26 53,000 1,656,780 136,002 Aug 06 04:23 PM Kelderman Kim Chief Executive Officer Jul 31 '24 Option Exercise 37.70 14,000 527,800 49,421 Aug 02 04:17 PM Hippel James CFO Jul 23 '24 Option Exercise 31.26 35,000 1,094,100 107,284 Jul 25 04:31 PM HIGGINS JOHN L Director Jul 08 '24 Option Exercise 22.95 6,000 137,700 42,608 Jul 10 04:35 PM HIGGINS JOHN L Director May 14 '24 Option Exercise 22.95 4,000 91,800 40,608 May 16 04:17 PM HIGGINS JOHN L Director May 14 '24 Sale 83.84 4,000 335,377 36,608 May 16 04:17 PM Nusse Roeland Director Mar 07 '24 Sale 76.98 10,400 800,627 43,097 Mar 11 04:04 PM Hippel James CFO Dec 19 '23 Option Exercise 31.26 47,289 1,478,254 104,850 Dec 21 04:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite